Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $9.21 in the prior trading day, Vir Biotechnology Inc (NASDAQ: VIR) closed at $8.65, down -6.08%. In other words, the price has decreased by -$6.08 from its previous closing price. On the day, 1.05 million shares were traded. VIR stock price reached its highest trading level at $8.76 during the session, while it also had its lowest trading level at $8.4175.
Ratios:
Our goal is to gain a better understanding of VIR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.51 and its Current Ratio is at 12.51. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 29, 2024, Downgraded its rating to Neutral and sets its target price to $9 from $23 previously.
On September 08, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $23 to $14.
JP Morgan Upgraded its Neutral to Overweight on March 06, 2023, whereas the target price for the stock was revised from $35 to $34.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 11 ’24 when Ramasastry Saira sold 4,000 shares for $10.95 per share. The transaction valued at 43,789 led to the insider holds 14,619 shares of the business.
De Backer Marianne sold 72,995 shares of VIR for $690,365 on Apr 03 ’24. The Chief Executive Officer now owns 678,457 shares after completing the transaction at $9.46 per share. On Apr 01 ’24, another insider, HANLY ANN M., who serves as the EVP & Chief Technology Officer of the company, sold 2,711 shares for $10.05 each. As a result, the insider received 27,251 and left with 132,069 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VIR now has a Market Capitalization of 1181936000 and an Enterprise Value of 145380288. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.98 while its Price-to-Book (P/B) ratio in mrq is 0.82. Its current Enterprise Value per Revenue stands at 1.843 whereas that against EBITDA is -0.291.
Stock Price History:
Over the past 52 weeks, VIR has reached a high of $14.27, while it has fallen to a 52-week low of $7.61. The 50-Day Moving Average of the stock is -12.78%, while the 200-Day Moving Average is calculated to be -10.61%.
Shares Statistics:
The stock has traded on average 1.14M shares per day over the past 3-months and 813110 shares per day over the last 10 days, according to various share statistics. A total of 134.78M shares are outstanding, with a floating share count of 89.63M. Insiders hold about 34.40% of the company’s shares, while institutions hold 52.79% stake in the company. Shares short for VIR as of 1721001600 were 4745637 with a Short Ratio of 4.16, compared to 1718323200 on 6826201. Therefore, it implies a Short% of Shares Outstanding of 4745637 and a Short% of Float of 5.6700002.
